Funding Source: Dept. of the Army
Funding Type: Discretionary, Grant/Cooperative Agreement
Total Available: $60 Million
Award Ceiling: N/A
Deadline: 02.17.10
Eligibility: Unrestricted
Description:
This Program Announcement/Funding Opportunity is focused on basic research, defined as research directed towards attaining greater knowledge and understanding of fundamental principles of science and medicine. The DMRDP Basic Research Award is designed to promote new ideas that are still in the early stages of development and have the potential to yield highly impactful data and new avenues of investigation. This mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will accelerate the delivery of new medical countermeasures and information to protect military personnel from a variety of health threats inherent in the military operational environment, and to effectively diagnose and treat these personnel when they are ill or injured. These awards will also support basic research to enhance the training and education of military personnel and health care providers. Presentation of preliminary data is not required. However, investigators must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the proposal to be competitive. Research projects should include a well-formulated, testable hypothesis based on strong scientific rationale. Awards under this announcement will consist solely of assistance agreements. This announcement is intended only for extramural investigators. Other announcements will be released for intramural investigators. An intramural investigator is defined as a Department of Defense (DOD) employee working within a DOD laboratory or medical treatment facility (MTF), or a DOD activity embedded within a civilian medical center. An extramural investigator is defined as all those not included in the definition of intramural investigator.
No comments:
Post a Comment